The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China.
Cancer Med. 2023 Jul;12(14):15579-15587. doi: 10.1002/cam4.6204. Epub 2023 Jun 7.
It is unknown whether financial well-being mediates the impact of multimorbidity on the health-related quality of life (HRQoL) of cancer patients.
Participants were recruited from three outpatient oncology clinics of Hong Kong public hospitals. Multimorbidity was assessed using the Charlson Comorbidity Index. Financial well-being, the mediator of the association between multimorbidity and HRQoL outcomes, was assessed using the Comprehensive Score for Financial Toxicity Functional Assessment of Chronic Illness Therapy. The HRQoL outcomes were assessed using the Functional Assessment of Cancer Therapy - General (FACT-G) and its four sub-dimensions. Mediation analyses were conducted using SPSS PROCESS v4.1.
Six-hundred and forty cancer patients participated in the study. Multimorbidity had a direct effect on FACT-G scores independent of financial well-being (β for path c' = -0.752, p < 0.001). In addition, multimorbidity had an indirect effect on FACT-G scores through its effect on financial well-being (β for path a = -0.517, p < 0.05; β for path b = 0.785, p < 0.001). Even after adjustments were made for the covariates, the indirect effect of multimorbidity on FACT-G via financial well-being remained significant, accounting for 38.0% of the overall effect, indicating partial mediation. Although there were no statistically significant associations between multimorbidity, social well-being, and emotional well-being, the indirect effects of multimorbidity on physical and functional well-being through financial well-being remained significant.
Poor financial well-being attributable to multimorbidity partially mediates the direct impact of chronic conditions on HRQoL in Chinese cancer patients, particularly their physical and functional well-being.
目前尚不清楚财务状况是否会调节多病共存对癌症患者健康相关生活质量(HRQoL)的影响。
参与者从香港公立医院的三个门诊肿瘤诊所招募。使用 Charlson 合并症指数评估多病共存。使用慢性病治疗的综合财务毒性功能评估量表来评估财务状况,作为关联多疾病与 HRQoL 结果的中介。使用癌症治疗功能评估-一般(FACT-G)及其四个子维度来评估 HRQoL 结果。使用 SPSS PROCESS v4.1 进行中介分析。
640 名癌症患者参与了这项研究。多病共存对 FACT-G 评分有直接影响,独立于财务状况(路径 c'的β=−0.752,p<0.001)。此外,多病共存通过对财务状况的影响对 FACT-G 评分产生间接影响(路径 a 的β=−0.517,p<0.05;路径 b 的β=0.785,p<0.001)。即使在调整了协变量后,多病共存通过财务状况对 FACT-G 的间接影响仍然显著,占总效应的 38.0%,表明部分中介作用。尽管多病共存与社会幸福感和情感幸福感之间没有统计学上的显著关联,但多病共存通过财务状况对身体和功能幸福感的间接影响仍然显著。
多病共存导致的财务状况不佳部分调节了慢性疾病对中国癌症患者 HRQoL 的直接影响,特别是对其身体和功能幸福感的影响。